ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 738

$908K Total Retail Price of All Prescriptions

Rank: 38 out of 738

547 Patients Receiving at Least One Drug in Part D
40%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 2,729 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ZOLPIDEM TARTRATE 493 177 1 3
ALPRAZOLAM 471 159 2 17
TRAZODONE HCL 442 135 3 1
RISPERIDONE 369 84 4 2
CYMBALTA 324 93 5 11
LAMOTRIGINE 321 71 6 12
SERTRALINE HCL 287 118 7 5
FLUOXETINE HCL 287 70 7 8
CITALOPRAM HBR 283 159 9 4
BUPROPION XL 253 92 10 15
MIRTAZAPINE 245 154 11 10
SEROQUEL XR 225 61 12 13
BENZTROPINE MESYLATE 212 21 R 13 6
PAROXETINE HCL 201 82 14 16
LORAZEPAM 162 66 15 34
BUSPIRONE HCL 141 61 16 20
QUETIAPINE FUMARATE 137 35 17 9
ZIPRASIDONE HCL 135 21 18 36
CLONAZEPAM 135 37 18 30
ESCITALOPRAM OXALATE 128 39 20 14
OLANZAPINE 116 14 21 18
DIVALPROEX SODIUM 106 69 22 23
AMPHETAMINE SALT COMBO 105 0 S2 23 37
LITHIUM CARBONATE 103 22 24 25
ABILIFY 99 26 25 7
FANAPT 98 0 26 83
GABAPENTIN 94 12 27 33
VENLAFAXINE HCL ER 92 39 28 19
VENLAFAXINE HCL 90 30 29 40
OXCARBAZEPINE 85 17 30 44
DONEPEZIL HCL 84 60 31 21
BUPROPION HCL SR 83 45 32 22
HALOPERIDOL 77 26 33 29
PRISTIQ ER 76 29 34 41
NAMENDA 71 59 35 26
TOPIRAMATE 70 11 36 39
ROPINIROLE HCL 69 0 37 103
DIAZEPAM 68 13 38 60
TEMAZEPAM 67 34 39 28
HYDROXYZINE PAMOATE 63 23 R 40 32
CLONIDINE HCL 52 0 41 86
CARISOPRODOL 51 0 R 42 75
GEODON 50 0 43 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.